Lipz/Lipz ED Contraindications

LIPZ and LIPZ ED is contraindicated in people with: Hypersensitivity to ethinylestradiol, drospirenone, or any component of the product (See Description).
Undiagnosed abnormal vaginal bleeding.
History of or current thromboembolic disorders (e.g., valvular heart disease with thrombogenic complications, deep vein thrombosis, or pulmonary embolism), history of coronary artery disease or cerebral vascular disease (e.g., myocardial infarction or stroke), or uncontrolled hypertension.
Heavy smoking (at least 15 cigarettes daily) and being older than 35 years of age.
Headaches with focal neurological symptoms (characterized by visual symptoms, speech disability, or weakness in any part of the body).
Diabetes with vascular complications.
Known or suspected breast carcinoma, estrogen-dependent neoplasia, or carcinoma of endometrium.
Hepatic adenomas or carcinomas, or active liver disease.
Cholestatic jaundice of pregnancy or jaundice with prior pill use.
Known or suspected pregnancy.
Major surgery with prolonged immobility.
Severe kidney insufficiency or acute kidney failure.
Coadministration with any antiviral medicines containing ombitasvir, paritaprevir, or dasabuvir, or any combinations of these. These antiviral medicines are used to treat chronic (long-term) hepatitis C (an infectious disease that affects the liver, caused by the hepatitis C virus).